Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company, on Wednesday announced the appointment of Todd Baumgartner as Chief Regulatory Officer.
Baumgartner, with over 35 years of experience, will be responsible for heading Applied's global regulatory strategy.
Before joining the company, Baumgartner served as Senior Vice President of Global Regulatory Affairs, Pharmacovigilance, and Biometrics at Ovid Therapeutics.
Tuesday, Applied Therapeutics had closed 4.70% lesser at $0.52 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.